The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Vor Biopharma Inc (NASDAQ: VOR) closed at $25.5 in the last session, down -5.29% from day before closing price of $26.92. In other words, the price has decreased by -$5.29 from its previous closing price. On the day, 0.95 million shares were traded. VOR stock price reached its highest trading level at $26.79 during the session, while it also had its lowest trading level at $23.12.
Ratios:
We take a closer look at VOR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.49 and its Current Ratio is at 3.49.
On September 24, 2025, Stifel Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $55.
H.C. Wainwright Upgraded its Neutral to Buy on June 30, 2025, while the target price for the stock was maintained at $3.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 27 ’25 when RA CAPITAL MANAGEMENT, L.P. sold 90,941 shares for $28.12 per share. The transaction valued at 2,557,261 led to the insider holds 1,180,060 shares of the business.
RA CAPITAL MANAGEMENT, L.P. sold 76,880 shares of VOR for $2,153,409 on Oct 23 ’25. The Director now owns 1,324,346 shares after completing the transaction at $28.01 per share. On Oct 24 ’25, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, sold 53,345 shares for $28.01 each. As a result, the insider received 1,494,193 and left with 1,271,001 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VOR now has a Market Capitalization of 174774624 and an Enterprise Value of -39044024.
Stock Price History:
The Beta on a monthly basis for VOR is 1.99, which has changed by 0.5178572 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, VOR has reached a high of $65.80, while it has fallen to a 52-week low of $2.62. The 50-Day Moving Average of the stock is -26.30%, while the 200-Day Moving Average is calculated to be 1.93%.
Shares Statistics:
According to the various share statistics, VOR traded on average about 342.31K shares per day over the past 3-months and 428540 shares per day over the past 10 days. A total of 6.28M shares are outstanding, with a floating share count of 5.67M. Insiders hold about 17.11% of the company’s shares, while institutions hold 29.36% stake in the company. Shares short for VOR as of 1760486400 were 1236759 with a Short Ratio of 3.61, compared to 1757894400 on 1101218. Therefore, it implies a Short% of Shares Outstanding of 1236759 and a Short% of Float of 42.41.
Earnings Estimates
The dynamic stock of Vor Biopharma Inc (VOR) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$2.4, with high estimates of -$0.8 and low estimates of -$4.0.
Analysts are recommending an EPS of between -$82.89 and -$264.6 for the fiscal current year, implying an average EPS of -$173.74. EPS for the following year is -$9.85, with 3.0 analysts recommending between -$1.95 and -$15.6.
